Neuland starts first module of commercial peptide plant with 7,000L capacity

The wire

1. 01Neuland Laboratories began operations at the first of four planned modules, with 7,000L reactor capacity, three DAC columns and two lyophilisers, staffed by about 212 peptide specialists.
2. 02More outsourced peptide API capacity matters to sponsors competing for manufacturing slots as pipelines expand beyond obesity into oncology.
3. 03A second module of up to 18,000L is being configured with anchor customers; timing depends on those requirements being finalised.

From the source

Neuland begins operations at first module of commercial peptide facility

New module offers 7,000L reactor capacity and supports complex peptide APIs, while second module planning advances with customer requirements